Monday was quite the day for biotech companies developing the next generation of obesity drugs. One of them, Structure Therapeutics ( GPCR +102.49%), skyrocketed almost 103% higher in price that day …
Why Structure Therapeutics Stock Doubled and Then Some on Monday
view original post